Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

× No keyword cloud information.

68 in total

1. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.

Authors: S C Redd; G W Rutherford; M A Sande; A R Lifson; W K Hadley; R R Facklam; J S Spika
Journal: J Infect Dis Date: 1990-11 Impact factor: 5.226

2. Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine.

Authors: S Jonsson; G Vidarsson; H Valdimarsson; G Schiffman; R Schneerson; I Jonsdottir
Journal: Eur Respir J Date: 2002-10 Impact factor: 16.671

3. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?

Authors: D M Musher; D A Watson; R E Baughn
Journal: J Infect Dis Date: 1990-04 Impact factor: 5.226

Review 4. Pneumococcal polysaccharide vaccine.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 1989-02-10 Impact factor: 17.586

5. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules.

Authors: G S Nabors; P A Braun; D J Herrmann; M L Heise; D J Pyle; S Gravenstein; M Schilling; L M Ferguson; S K Hollingshead; D E Briles; R S Becker
Journal: Vaccine Date: 2000-03-06 Impact factor: 3.641

6. A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides.

Authors: M H Nahm; G R Siber; J V Olander
Journal: J Infect Dis Date: 1996-01 Impact factor: 5.226

7. Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay.

Authors: J I Ward; D P Greenberg; P W Anderson; K S Burkart; P D Christenson; L K Gordon; H Kayhty; J S Kuo; P Vella
Journal: J Clin Microbiol Date: 1988-01 Impact factor: 5.948

8. Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.

Authors: Louis Vernacchio; Henry Bernstein; Steve Pelton; Carole Allen; Kristin MacDonald; Jessica Dunn; David D Duncan; Grace Tsao; Vincent LaPosta; John Eldridge; Suzanne Laussucq; Donna M Ambrosino; Deborah C Molrine
Journal: Vaccine Date: 2002-11-01 Impact factor: 3.641

9. Natural and vaccine-related immunity to Streptococcus pneumoniae.

Authors: D M Musher; A J Chapman; A Goree; S Jonsson; D Briles; R E Baughn
Journal: J Infect Dis Date: 1986-08 Impact factor: 5.226

10. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.

Authors: H Jakobsen; D Schulz; M Pizza; R Rappuoli; I Jónsdóttir
Journal: Infect Immun Date: 1999-11 Impact factor: 3.441

107 in total

1. Assignment of Weight-Based Antibody Units for Seven Additional Serotypes to a Human Pneumococcal Standard Reference Serum, 007sp.

Authors: D Goldblatt; C Y Tan; P Burbidge; S McElhiney; L McLaughlin; R Tucker; M Rauh; M Sidhu; P C Giardina
Journal: Clin Vaccine Immunol Date: 2015-09-09

Review 2. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies.

Authors: R A Fleck; S Romero-Steiner; M H Nahm
Journal: Clin Diagn Lab Immunol Date: 2005-01

3. Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae.

Authors: Joseph E Martinez; Elizabeth A Clutterbuck; Han Li; Sandra Romero-Steiner; George M Carlone
Journal: Clin Vaccine Immunol Date: 2006-04

4. Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.

Authors: Meng Chen; Yuki Hisatomi; Akitsugu Furumoto; Kenji Kawakami; Hironori Masaki; Tsuyoshi Nagatake; Yoshiko Sueyasu; Tomoaki Iwanaga; Hisamichi Aizawa; Kazunori Oishi
Journal: Clin Vaccine Immunol Date: 2006-12-13

Review 5. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines.

Authors: Sandra Romero-Steiner; Carl E Frasch; George Carlone; Roland A Fleck; David Goldblatt; Moon H Nahm
Journal: Clin Vaccine Immunol Date: 2006-02

6. Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Authors: Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Journal: Vaccine Date: 2010-05-12 Impact factor: 3.641

7. Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease.

Authors: H E Baxendale; M Johnson; R C M Stephens; J Yuste; N Klein; J S Brown; D Goldblatt
Journal: Clin Exp Immunol Date: 2007-11-05 Impact factor: 4.330

8. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.

Authors: Hyunju Lee; Moon H Nahm; Robert Burton; Kyung-Hyo Kim
Journal: Clin Vaccine Immunol Date: 2009-01-14

9. Multilaboratory assessment of threshold versus fold-change algorithms for minimizing analytical variability in multiplexed pneumococcal IgG measurements.

Authors: Thomas M Daly; Jerry W Pickering; Xiaochun Zhang; Harry E Prince; Harry R Hill
Journal: Clin Vaccine Immunol Date: 2014-05-07

10. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.

Authors: Ron Dagan; David Goldblatt; James R Maleckar; Mansour Yaïch; Juhani Eskola
Journal: Infect Immun Date: 2004-09 Impact factor: 3.441